SGLT Inhibitors for Heart and Kidney Disease in Type 1 Diabetes.

Rosen J, de Boer IH, Eckel RH, McGuire DK, Peters AL, Pop-Busui R, Tuttle KR, Vaduganathan M, Dutta S

Open source

DOI
10.2337/dc26-0999
Published
2026 Sep 3
Container
Diabetes care
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2337/dc26-0999,
  title = {SGLT Inhibitors for Heart and Kidney Disease in Type 1 Diabetes.},
  author = {Rosen J and de Boer IH and Eckel RH and McGuire DK and Peters AL and Pop-Busui R and Tuttle KR and Vaduganathan M and Dutta S},
  year = {2026},
  journal = {Diabetes care},
  doi = {10.2337/dc26-0999},
  url = {https://doi.org/10.2337/dc26-0999}
}

RIS

TY  - JOUR
TI  - SGLT Inhibitors for Heart and Kidney Disease in Type 1 Diabetes.
AU  - Rosen J
AU  - de Boer IH
AU  - Eckel RH
AU  - McGuire DK
AU  - Peters AL
AU  - Pop-Busui R
AU  - Tuttle KR
AU  - Vaduganathan M
AU  - Dutta S
PY  - 2026
JO  - Diabetes care
DO  - 10.2337/dc26-0999
UR  - https://doi.org/10.2337/dc26-0999
ER  - 

APA

J, R., IH, D. B., RH, E., DK, M., AL, P., R, P., KR, T., M, V., & S, D. (2026). SGLT Inhibitors for Heart and Kidney Disease in Type 1 Diabetes.. Diabetes care. https://doi.org/10.2337/dc26-0999

Source records